Biosimulation Market - Forecasts from 2017 to 2022

  • ID: 4032546
  • Report
  • 102 pages
  • Knowledge Sourcing Intelligence LLP
1 of 4

FEATURED COMPANIES

  • Certara USA, Inc.
  • Dassault Systemes BIOVIA
  • Genedata AG
  • InhibOx Ltd
  • Physiomics PLC
  • Schrodinger, LLC
  • MORE
Biosimulation is used in the healthcare sector for model-based calculation of biological systems. It is helpful in making commercial decisions regarding the benefits of bringing a specific drug to market. In 2022, the market for biosimulation is expected to reach US$3,435 million, increasing from US$1,476 million in 2017, at a CAGR of 18.40%.

Factors driving the biosimulation market growth are increased medical research and development across emerging economies, technological advancement in drug development processes, robust pace of clinical trials and a favorable regulatory environment in developed regions like the US and Europe. Rising demand for reduced drug development costs coupled with penetration of digital and computer technology and improvement in modeling tools has fuelled further market growth. Geographically, North America is the expected to remain the largest biosimulation market over the projected period followed by Europe.

Research Methodology

The first section of the report deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segmentations which have been covered as part of the report.

Market Dynamics

Next section provides comprehensive market dynamics through an overview section along with growth drivers, challenges, and opportunities which exist in the current market. This section of the report also provides supplier and industry outlook, key industry and regional regulations which are determining the product specifications and a brief technological aspect of Biosimulation. Complete industry analysis has also been covered by Porter’s five forces model as a part of this report section.

Segmentation

The Biosimulation market has been segmented by type, applications, end-user industry and geography.

By Type:
Software
Services

By Application:
Drug Development
Drug Discovery
Others

By End-User Industry:
Pharmaceutical Companies
Academic Institutions
Research Organizations
Others

By Geography:
Americas
North America
South America
Europe Middle East & Africa
Europe
The Middle East & Africa
Asia Pacific

Market Players

Finally, competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others. Key industry players in the Biosimulation market are Certara USA, Inc., Advanced Chemistry Development, Inc., Schrodinger, LLC and Simulations Plus among others.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Certara USA, Inc.
  • Dassault Systemes BIOVIA
  • Genedata AG
  • InhibOx Ltd
  • Physiomics PLC
  • Schrodinger, LLC
  • MORE
1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics
4.1. Market Overview and Segmentations
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Supplier Outlook
4.6. Industry Outlook
4.7. Porter’s 5 Forces Analysis
4.8. Industry Value Chain Analysis
4.9. Scenario Analysis

5. Biosimulation Market Forecast by Type (US$ million)
5.1. Software
5.2. Services

6. Biosimulation Market Forecast by Application (US$ million)
6.1. Drug Development
6.2. Drug Discovery
6.3. Others

7. Biosimulation Market Forecast by End-User Industry (US$ million)
7.1. Pharmaceutical Companies
7.2. Academic Institutions
7.3. Research Organizations
7.4. Others

8. Biosimulation Market Forecast by Geography (US$ million)
8.1. Americas
8.1.1. North America
8.1.2. South America
8.2. Europe Middle East and Africa
8.2.1. Europe
8.2.2. Middle East and Africa
8.3. Asia Pacific

9. Competitive Intelligence
9.1. Market Share of Key Players
9.2. Investment Analysis
9.3. Recent Deals
9.4. Strategies of Key Players

10. Company Profiles
10.1. Certara USA, Inc.
10.2. Advanced Chemistry Development, Inc.
10.3. Schrodinger, LLC
10.4. Simulations Plus
10.5. Chemical Computing Group Inc.
10.6. Dassault Systemes BIOVIA
10.7. In Silico Biosciences, Inc.
10.8. InhibOx Ltd
10.9. LeadInvent Technologies Pvt. Ltd.
10.10. Genedata AG
10.11. Physiomics PLC

List of Tables

Table 1: Biosimulation Market Forecast, 2017 to 2022, US$ million
Table 2: Biosimulation Market Forecast, 2017 to 2022, By Type, US$ million
Table 3: Biosimulation Market Forecast, 2017 to 2022, By Type, Software, By Region, US$ million
Table 4: Biosimulation Market Forecast, 2017 to 2022, By Type, Services, By Region, US$ million
Table 5: Biosimulation Market Forecast, 2017 to 2022, By Application, US$ million
Table 6: Biosimulation Market Forecast, 2017 to 2022, By Application, Drug Development, By Region, US$ million
Table 7: Biosimulation Market Forecast, 2017 to 2022, By Application, Drug Discovery, By Region, US$ million
Table 8: Biosimulation Market Forecast, 2017 to 2022, By Application, Others, By Region, US$ million
Table 9: Biosimulation Market Forecast, 2017 to 2022, By End-User, US$ million
Table 10: Biosimulation Market Forecast, 2017 to 2022, By End-User, Pharmaceutical Companies, By Region, US$ million
Table 11: Biosimulation Market Forecast, 2017 to 2022, By End-User, Academic Institutes, By Region, US$ million
Table 12: Biosimulation Market Forecast, 2017 to 2022, By End-User, Research Organizations, By Region, US$ million
Table 13: Biosimulation Market Forecast, 2017 to 2022, By End-User, Others, By Region, US$ million
Table 14: Biosimulation Market Forecast, 2017 to 2022, By Region, US$ million
Table 15: Biosimulation Market Forecast, 2017 to 2022, By Region, Americas, US$ million
Table 16: Biosimulation Market Forecast, 2017 to 2022, By Region, Europe Middle East and Africa, US$ million
Table 17: Biosimulation Market Forecast, 2017 to 2022, By Region, Asia Pacific, US$ million
Table 18: Biosimulation Market Forecast, 2017 to 2022, By Type, North America, US$ million
Table 19: Biosimulation Market Forecast, 2017 to 2022, By Application, North America, US$ million
Table 20: Biosimulation Market Forecast, 2017 to 2022, By End User, North America, US$ million
Table 21: Biosimulation Market Forecast, 2017 to 2022, By Type, South America, US$ million
Table 22: Biosimulation Market Forecast, 2017 to 2022, By Application, South America, US$ million
Table 23: Biosimulation Market Forecast, 2017 to 2022, By End User, South America, US$ million
Table 24: Biosimulation Market Forecast, 2017 to 2022, By Type, Europe, US$ million
Table 25: Biosimulation Market Forecast, 2017 to 2022, By Application, Europe, US$ million
Table 26: Biosimulation Market Forecast, 2017 to 2022, By End User, Europe, US$ million
Table 27: Biosimulation Market Forecast, 2017 to 2022, By Type, Middle East and Africa, US$ million
Table 28: Biosimulation Market Forecast, 2017 to 2022, By Application, Middle East and Africa, US$ million
Table 29: Biosimulation Market Forecast, 2017 to 2022, By End User, Middle East and Africa, US$ million
Table 30: Biosimulation Market Forecast, 2017 to 2022, By Type, Asia Pacific, US$ million
Table 31: Biosimulation Market Forecast, 2017 to 2022, By Application, Asia Pacific, US$ million
Table 32: Biosimulation Market Forecast, 2017 to 2022, By End User, Asia Pacific, US$ million
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Certara USA, Inc.
  • Advanced Chemistry Development, Inc.
  • Schrodinger, LLC
  • Simulations Plus
  • Chemical Computing Group Inc.
  • Dassault Systemes BIOVIA
  • In Silico Biosciences, Inc.
  • InhibOx Ltd
  • LeadInvent Technologies Pvt. Ltd.
  • Genedata AG
  • Physiomics PLC
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll